1)Porter GA, Baxter N and Pisters PW:Retroperitoneal sarcoma:a population-based analysis of epidemiology, surgery, and radiotherapy. Cancer 106:1610-1616, 2006
2)Dalal KM, Antonescu CR and Singer S:Diagnosis and management of lipomatous tumors. J Surg Oncol 97:298-313, 2008
3)土井俊邦,藤田一郎,河 源,他:腎被膜脂肪肉腫の1例.泌尿紀要 41:873-877,1995
4)Singer S, Antonescu CR, Riedel E, et al:Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Ann Surg 238:358-370, 2003
5)Lahat G, Madewell JE, Anaya DA, et al:Computed tomography scan-driven election of treatment for retroperitoneal liposarcoma histologic subtypes. Cancer 115:1081-1090, 2009
6)Song T, Shen J, Liang BL, et al:Retroperitoneal liposarmcoa:MR characteristics and pathological correlative analysis. Abdom Imaging 32:668-674, 2007
7)Dalal KM, Kattan MW, Antonescu CR, et al:Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk. Ann Surg 244:381-391, 2006
8)Binder SC, Katz B and Sheridan B:Retroperitoneal liposarcoma. Ann Surg 187:257-261, 1978
9)Fein DA, Corn BW, Lanciano RM, et al:Management of retroperitoneal sarcomas:does dose escalation impact on locoregional control? Int J Radiat Oncol Biol Phys 31:129-134, 1995
10)Petrioli R, Coratti A, Correale P, et al:Adjuvant epirubicin with or without Ifosfamide for adult soft-tissue sarcoma. Am J Clin Oncol 25:468-473, 2002